Experimental chemotherapy of schistosomiasis. VII. Laboratory and clinical trials with sodium antimony dimethylcysteine tartrate (NaP).
D000328:Adult; D000818:Animals; D000965:Antimony / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006224:Cricetinae; D004341:Drug Evaluation; D000882:Haplorhini; D006801:Humans; D051379:Mice; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use*; D012552:Schistosomiasis / Q000188:drug therapy*; D012964:Sodium / Q000009:adverse effects / Q000627:therapeutic use*; D013644:Tartrates / Q000627:therapeutic use
D013644:Tartrates; D000965:Antimony; D012964:Sodium; D010396:Penicillamine